Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges

Affiliations

Brian S. Barnett: Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States
Brian S. Barnett: Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, United States
Anahita Bassir Nia: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States
Nathan B. Sackett: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States
Nathan B. Sackett: Center for Novel Therapeutics in Addiction Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States
Jeremy Weleff: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States

Abstract

No abstracts available.

ISSN: 1664-0640 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry
Website: https://www.frontiersin.org/journals/psychiatry